Circulation

Vol. 151, Issue 6 Issue 6 2025
12
Articles

Articles in this Issue

Cox Regression Model in Clinical Research: Overview of Key Properties and Interpretation

Andrea Bellavia, Sabina A. Murphy Feb 11, 2025 pp. 337-339 10.1161/circulationaha.124.072956

Association of Coagulation Factor XI Level With Cardiovascular Events and Cardiac Function in Community-Dwelling Adults: From ARIC and CHS

Yuekai Ji, Michael J. Zhang, Wendy Wang et al. Feb 11, 2025 pp. 356-367 10.1161/circulationaha.124.070278

BACKGROUND: Coagulation factor XI (FXI) inhibitors are a promising and novel class of anticoagulants, but a recent animal study found that FXI inhibition exacerbated diastolic dysfunction...

Antagonizing HFpEF by Targeting Fibrosis

Glynnis Garry Bann Feb 11, 2025 pp. 396-399 10.1161/circulationaha.124.072973

Global Rounds: Advancing Cardiovascular Health in China

Changsheng Ma, Junbo Ge, Yaling Han Feb 11, 2025 pp. 340-342 10.1161/circulationaha.124.071544

Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction

Yu Yamada, Taketaro Sadahiro, Koji Nakano et al. Feb 11, 2025 pp. 379-395 10.1161/circulationaha.123.067504

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is a major health concern. Pathological stimuli and interactions between cardiac fibroblasts (CFs) and oth...

Response by Shen et al to Letter Regarding Article, “Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF”

Li Shen, Pardeep S. Jhund, John J.V. McMurray Feb 11, 2025 10.1161/circulationaha.124.072690

Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention

Felice Gragnano, David van Klaveren, Dik Heg et al. Feb 11, 2025 pp. 343-355 10.1161/circulationaha.124.072009

BACKGROUND: Accurate bleeding risk stratification after percutaneous coronary intervention is important for treatment individualization. However, there is still an unmet need for a more pr...

Letter by Tunçez and Gürses Regarding Article, “Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF”

Abdullah Tunçez, Kadri Murat Gürses Feb 11, 2025 10.1161/circulationaha.124.071627

Major Adverse Cardiovascular Events 1 Year After Discharge in Out-of-Hospital Cardiac Arrest Survivors

Sang-Min Kim, Sehee Kim, Ye-Jee Kim et al. Feb 11, 2025 pp. 421-423 10.1161/circulationaha.124.070680

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects

Antonio Greco, Simone Finocchiaro, Marco Spagnolo et al. Feb 11, 2025 pp. 400-415 10.1161/circulationaha.124.069210

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk fa...

Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy

Corentin Chaumont, Eliot G. Peyster, Konstantinos C. Siontis et al. Feb 11, 2025 pp. 368-378 10.1161/circulationaha.124.070501

BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired...

Transcatheter Repair Versus Surgery for Atrial Versus Ventricular Functional Mitral Regurgitation: A Post Hoc Analysis of the MATTERHORN Trial

Felix Rudolph, Martin Geyer, Stephan Baldus et al. Feb 11, 2025 pp. 418-420 10.1161/circulationaha.124.072648

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page